Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens-backed CityMD will pay $12.04 million to settle Covid fraud allegations brought by the Department of Justice. For two years of the pandemic, CityMD allegedly obtained fraudulent government reimbursements for Covid tests by submitting false claims to a Covid program specifically designated for uninsured patients, even when their patients had health insurance.

DOJ settles CityMD Covid fraud allegations for $12 million

Altria

Verizon

Walgreens Boots Alliance cut its dividend earlier this year, but even with the new payout, its yield remains high. Altria faces a challenging road ahead as tobacco use declines, but the company's dividend still looks safe right now.

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Atmos Energy

PepsiCo

It's no secret that we all love to get paid. And when you think about it, dividend stock payments are essentially investors' versions of paydays within the stock market.

What You Should Know About Dividend Paying Stocks

Walgreens Boots Alliance has shelved plans for a potential initial public offering of its UK-based Boots drugstore chain as sale talks continue, Bloomberg News reported on Friday citing people with knowledge of the matter.

Walgreens shelves plans for Boots IPO, Bloomberg News reports

CVS Health

Herbalife

Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.

2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry

Gilead Sciences

Kraft Heinz

Walgreens has lost some 70% of its value, and the stock now yields 6.5%. Kraft Heinz has experienced a similar slump, and its shares offer a 4.6% yield.

Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100?

Given its better valuation, we believe Walgreens stock (NYSE: WBA) is a better pick than its peer CVS Health stock (NYSE: CVS). WBA stock trades at 0.1x revenues, versus 0.2x for CVS, given the latter's superior revenue growth, profitability, and financial position.

After A 40% Fall Is Walgreens Stock A Better Pick Over CVS Health?

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2024 third quarter results at 7 a.m. ET on Thursday, June 27, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens B.

Walgreens Boots Alliance Schedules Fiscal 2024 Third Quarter Earnings Announcement for June 27

Annaly Capital

Income stocks have more than doubled the average annual return of non-payers over the last half-century. One of Wall Street's most-disliked industry's is concealing a plain-as-day bargain that's returned $25 billion in dividends to its shareholders since its initial public offering.

Time to Pounce: 2 Beaten-Down Ultra-High-Yield Dividend Stocks Begging to Be Bought in June

Walgreens Boots Alliance (WBA) reachead $15.92 at the closing of the latest trading day, reflecting a -1.85% change compared to its last close.

Walgreens Boots Alliance (WBA) Stock Declines While Market Improves: Some Information for Investors

Agree Realty

Broadstone Net Lease

Essential Properties Realty Trust Inc

Gladstone Commercial

NETSTREIT Corp

Realty Income Corp

Alpine Income Property Trust

Vici Properties

W. P. Carey

There is significant mispricing among triple net REITs due to a lack of consideration for changing the tenant landscape. Net store openings indicate positive occupancy and rental rates, but some REITs are exposed to troubled areas. REITs with exposure to CVS and Walgreens may face challenges with lease expirations, requiring substantial capex and potential revenue disruption.

Triple Net REITs Mispriced As Tenancy Shifts

Cracker Barrel Old Country Store

Medical Properties Trust

Walgreens Boots Alliance is deploying a costly healthcare strategy that puts pressure on its already low margins. Medical Properties Trust endured problems with tenants, and those issues aren't over just yet.

These 3 Dividend Stocks Slashed Their Payouts by More Than 40% Within the Past Year

Intel

Not all dividend stocks are good, and you should always keep an eye out for dividend stocks to sell if they don't perform well. Dividend payments from publicly traded companies reached a record $164.3 billion in this year's first quarter, up 7% from a year ago.

Dividend Duds: 3 Stocks to Dump Before They Drain Your Portfolio

Amazon

McDonald's

Target

Walmart

The topic of inflation relief is one most consumers can get behind. Inflation has been stickier than many expected, particularly in key categories.

Inflation Relief: Which Retail Giants Are Slashing Prices?

Retail pharmacy chain Walgreens (NASDAQ: WBA ) is seeing shares pop sharply higher on Thursday following a big announcement. Billed as a “summer of savings,” the company will lower prices on 1,300 items.

Walgreens Price Cuts Alert: Walgreens Slashes Product Prices to Court Shoppers

Walgreens has faced headwinds and cut its dividend by nearly 50% earlier this year. The company's recent earnings showed some positive signs, but headwinds persist, which could lead to an additional dividend cut by the end of the year. The dividend coverage is a concern as operating cash flow and free cash flow were negative in the first half of the year.

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

Shares of Walgreens Boots Alliance (WBA) fell over 3% Wednesday after the pharmacy retailer announced plans to join the growing list of retailers cutting prices to win back customers who have changed their shopping habits to deal with inflation.

Walgreens Joins Growing List of Retailers Cutting Prices To Win Back Customers

The pharmacy chain announced price cuts on items such as vitamins, hygiene products, toothbrushes, pain relief patches, hand cream and mini pretzels.

Walgreens to slash prices on 1,300 items — following Amazon, Walmart and Target — as inflation rages

Walgreens is cutting prices on more than 1,300 items as part of its “Summer of Savings,” the drug store chain announced Wednesday, joining a slew of big-box retailers slashing prices to boost sales amid persistent inflation.

Walgreens Joins Target, Amazon, Walmart In Announcing Steep Summer Price Cuts

Walgreens is joining a growing number of companies that are cutting prices on a number of goods to lure in shoppers and boost sales in the midst of inflation.

Walgreens cutting prices on 1,300 products

Walgreens Boots Alliance Inc. said Wednesday it was continuing to lower prices as part of its “Summer of Savings” promotional campaign, this time on more than 1,300 products — but that announcement didn't stop the drugstore chain's stock from falling toward a 27-year low.

Walgreens to cut prices on over 1,300 products as stock keeps sinking

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens today introduced more opportunities for consumers to save throughout the season and beyond. The company also plans to introduce a series of promotional campaigns, including the return of Walgreens popular myW Days in mid-July. “Walgreens understands our customers are under financial strain and struggle to purchase everyday essentials. We continue to be committed to our customers by lowering prices on over a thousand additional items, something we've b.

Walgreens Introduces Summer of Savings

CVS, Walmart, and Walgreens are all scaling back or shuttering retail health clinics.  Walgreens' VillageMD recorded a $6 billion loss, an example of just how difficult it has become to generate profits from a health-care model that retailers over the past decade bet would be a big win.

Why Walmart, Walgreens, CVS retail health clinic experiment is struggling

Walgreens has been hurt by industry reimbursement pressures. The company also made a poor acquisition with its large investment in VillageMD.

Walgreens Boots Stock Just Hit Its Lowest Level Since 1998. Time to Buy the Dip or Stay Away?

Lumentum Holdings

Turing Holding Corp

The Nasdaq Composite‘s rally has yet to abate, but there are still Nasdaq stocks to sell. The tech-heavy index has risen over 11% and is likely to edge upwards.

News for Walgreens Stock (WBA)